May 14, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Youths who start using an automated insulin delivery system within 6 months of type 1 diabetes diagnosis are 82% more likely to have an HbA1c of less than 7% at 2 years than those who do not use a system, according to study data. In a study published in Diabetes Technology & Therapeutics, researchers obtained real-world data from 27 centers in the T1D Exchange Quality Improvement
May 14, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Teplizumab can allow patients to live “normal lives” without the need for insulin injections

The new technology, known as a hybrid closed loop system, will help reduce the risk of stillbirth and miscarriage

Teplizumab licensed for use by adults and older children in ‘breakthrough moment’

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin…

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those…

A new implant for diabetics carries a reservoir of glucagon that can be stored under the skin and released manually or…